NIPH Clinical Trials Search

JAPANESE
国立保健医療科学院
UMIN ID: UMIN000001656

Registered date:25/01/2009

Evaluation of efficacy and safety of active vitamin D treatment for secondary hyperparathyroidism in patients on maintenance hemodialysis; competitive study

Basic Information

Recruitment status Complete: follow-up complete
Health condition(s) or Problem(s) studiedsecondary hyperparathyroidism(SHPT)
Date of first enrollment2008/06/01
Target sample size40
Countries of recruitmentJapan
Study typeInterventional
Intervention(s)affacalcidol maxacalcitol

Outcome(s)

Primary OutcomeThe percentage achievement of recommendation value (60-180pg/mL) of intact parathyroid hormone(PTH).
Secondary Outcome

Key inclusion & exclusion criteria

Age minimum20years-old
Age maximum75years-old
GenderMale and Female
Include criteria
Exclude criteria1) Malignancy,malnutrition, active inflammatory or infectious disease 2)Severe heart failure and liver dysfunction 3)Pregnancy, during breast-feeding 4)Patients with allergy to affacalcidol and maxacalcitol 5)Primary hyperparathyroidism patients 6)Aluminum and Fe associated bone disease patients 7)Post parathyroidectomy patients, patients received percutaneous ethanol or vitamin D injection 8) Judged inappropriate for this study by the physicians 9)Parients who were recruited another clinical trial within 3 months

Related Information

Contact

public contact
Name
Address Japan
Telephone
E-mail hondah@med.showa-u.ac.jp
Affiliation Showa University Showa University School of Medicine Division of Nephrology Department of Medicine
scientific contact
Name Hirokazu Honda
Address 1-5-8, Hatanodai, Shinagawaku, Tokyo, Japan Japan
Telephone
E-mail
Affiliation Showa University School of Medicine Division of Nephrology , Department of Medicine